Literature DB >> 9023240

Autologous fat injection into the vocal folds: technical considerations and long-term follow-up.

G Y Shaw1, M A Szewczyk, J Searle, J Woodroof.   

Abstract

Numerous materials have been used over the years for vocal fold augmentation. Early use of bioreactive compounds, such as paraffin, gave way to relatively inert substances, such as Teflon. More recently biocompatible materials, such as collagen and autologous fat, have gained wider acceptance. Autologous fat, in particular, is an easily obtainable source for potential rehabilitation of scarred, paralytic, and atrophic vocal folds. However, long-term systematic follow-up has been lacking. Since 1991 we at the University of Kansas Center for Voice and Swallowing Disorders have employed autologous fat for vocal fold augmentation, primarily for either paralysis or repair of a volume-deficient vocal fold segment. Twenty-two patients have completed > or = 1 year of follow-up studies, including graded video-laryngostroboscopy, electroglottography, computerized acoustic analysis, and blinded perceptual analysis by two speech-language pathologists. Statistically significant improvement was demonstrated in many parameters tested, frequently improving with time. Although the volume-deficient group had more "normal" values, the paralysis group had greater improvement in many variables using fat injection. We conclude that while autologous fat injections of the vocal fold may have long-term benefits, certain technical considerations and criteria of selection of patients are critical for success.

Entities:  

Mesh:

Year:  1997        PMID: 9023240     DOI: 10.1097/00005537-199702000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  21 in total

1.  Evaluation of alloderm and autologous skin in quadriceps muscles of rats for injection laryngoplasty.

Authors:  A Sengor; O Aydin; F Mola; Y Gürbüz
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-02-18       Impact factor: 2.503

Review 2.  Technical considerations in fat augmentation for patients with glottic insufficiency.

Authors:  Ming-Wang Hsiung
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

Review 3.  [Vocal fold augmentation].

Authors:  C Sittel; P K Plinkert
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

4.  Effects of unilateral vocal cord paralysis on objective voice measures obtained by Praat.

Authors:  Haldun Oguz; Munir Demirci; Mustafa A Safak; Necmi Arslan; Ahmet Islam; Selda Kargin
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-11       Impact factor: 2.503

5.  Mesenchymal stromal cell injection promotes vocal fold scar repair without long-term engraftment.

Authors:  R S Bartlett; J T Guille; X Chen; M B Christensen; S F Wang; S L Thibeault
Journal:  Cytotherapy       Date:  2016-10       Impact factor: 5.414

6.  Treatment of vocal fold immobility by injectable homologous collagen: short-term results.

Authors:  Marc Remacle; Georges Lawson; Jacques Jamart; Monique Delos
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-09-22       Impact factor: 2.503

7.  Autologous Fat Augmentation in Post Type III Cordectomy Patients.

Authors:  Sachin Gandhi; Shashank Gupta; Nilanjan Bhowmick; Aniketh Pandurangi; Vrushali Desai
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-30

8.  Autogenous fat injection for vocal fold atrophy.

Authors:  Ming-Wang Hsiung; Yaoh-Shiang Lin; Wan-Fu Su; Hsing-Won Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

9.  Videostroboscopic assessment of unilateral vocal fold paralysis after augmentation with autologous fascia.

Authors:  Heikki Rihkanen; Petri Reijonen; Sari Lehikoinen-Söderlund; Eija-Riitta Lauri
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-08-26       Impact factor: 2.503

Review 10.  [Surgical voice rehabilitation in unilateral vocal fold paralysis].

Authors:  C Sittel; N Bosch; P K Plinkert
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.